Harmanjit Singh

7PUBLICATIONS
1CO-AUTHORS
Nutrigenomics and personalised nutritionMolecular targetsPharmacogenomicsAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 26, 2022
Potential approaches using teneligliptin for the treatment of type 2 diabetes mellitus: current status and future prospects.

Harmanjit Singh, Jasbir Singh, Ravneet Kaur Bhangu

|Dec 19, 2022
Dipeptidyl peptidase 4 (DPP-4) inhibitors and the risk of lung cancer: current evidence and future directions.

Harmanjit Singh, Jatin Sharma, Pallavi Sikarwar

|Mar 11, 2022
Alternate-day add-on therapy with dapagliflozin in patients with type 2 diabetes mellitus: potential benefits and concerns.

Harmanjit Singh, Dinesh Joshi, Seerat Narula

|Oct 16, 2021
Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy.

Prerna Chauhan, Gurjit Kaur, Rajendra Prasad

|Feb 15, 2021
Concomitant use of dexamethasone and tetracyclines: a potential therapeutic option for the management of severe COVID-19 infection?

Harmanjit Singh, Prerna Chauhan, Jasbir Singh

|Oct 16, 2020
Minocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges.

Prerna Chauhan, Ashish Kumar Kakkar, Harmanjit Singh

Pageof 2

Frequent Collaborators